DD210042A5 - Verfahren zur herstellung von (plus + minus)-zyanidan-3-ol-abkoemmlingen - Google Patents

Verfahren zur herstellung von (plus + minus)-zyanidan-3-ol-abkoemmlingen Download PDF

Info

Publication number
DD210042A5
DD210042A5 DD83251544A DD25154483A DD210042A5 DD 210042 A5 DD210042 A5 DD 210042A5 DD 83251544 A DD83251544 A DD 83251544A DD 25154483 A DD25154483 A DD 25154483A DD 210042 A5 DD210042 A5 DD 210042A5
Authority
DD
German Democratic Republic
Prior art keywords
radical
formula
optionally substituted
compounds
hydrogen
Prior art date
Application number
DD83251544A
Other languages
German (de)
English (en)
Inventor
Alban I Albert
Marc E Ballenegger
Jan C Overeem
Robert G Tyson
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of DD210042A5 publication Critical patent/DD210042A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD83251544A 1982-06-01 1983-05-31 Verfahren zur herstellung von (plus + minus)-zyanidan-3-ol-abkoemmlingen DD210042A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8215868 1982-06-01

Publications (1)

Publication Number Publication Date
DD210042A5 true DD210042A5 (de) 1984-05-30

Family

ID=10530751

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83251544A DD210042A5 (de) 1982-06-01 1983-05-31 Verfahren zur herstellung von (plus + minus)-zyanidan-3-ol-abkoemmlingen

Country Status (20)

Country Link
US (1) US4510159A (ja)
EP (1) EP0096008B1 (ja)
JP (1) JPS58219184A (ja)
KR (1) KR840005135A (ja)
AT (1) ATE41774T1 (ja)
AU (1) AU569033B2 (ja)
CA (1) CA1252108A (ja)
DD (1) DD210042A5 (ja)
DE (1) DE3379502D1 (ja)
DK (1) DK245383A (ja)
ES (1) ES522815A0 (ja)
FI (1) FI831927L (ja)
GB (1) GB2122987B (ja)
GR (1) GR78363B (ja)
HU (1) HU193537B (ja)
IL (1) IL68833A (ja)
NO (1) NO158805C (ja)
NZ (1) NZ204423A (ja)
PT (1) PT76783B (ja)
ZA (1) ZA833905B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431534A1 (de) * 1984-08-28 1986-03-13 Merck Patent Gmbh, 6100 Darmstadt Flavanonderivate
WO1987007835A1 (en) * 1986-06-21 1987-12-30 Dainippon Ink And Chemicals, Inc. Drug for treatment and prophylaxis of kidney and liver diseases
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
US4255336A (en) * 1977-11-25 1981-03-10 Ciba-Geigy Corporation Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01
DE3176349D1 (en) * 1980-04-03 1987-09-17 Zyma Sa Use of o-substituted derivatives of (+)-cyanidanol-3 as compounds with immunomodulative properties

Also Published As

Publication number Publication date
FI831927A0 (fi) 1983-05-30
IL68833A (en) 1987-10-30
NO158805B (no) 1988-07-25
NZ204423A (en) 1986-10-08
FI831927L (fi) 1983-12-02
PT76783A (en) 1983-06-01
ATE41774T1 (de) 1989-04-15
EP0096008A3 (en) 1984-01-11
JPS58219184A (ja) 1983-12-20
GB8312766D0 (en) 1983-06-15
KR840005135A (ko) 1984-11-03
AU1525683A (en) 1983-12-08
ES8502990A1 (es) 1985-02-01
EP0096008B1 (en) 1989-03-29
GB2122987A (en) 1984-01-25
HU193537B (en) 1987-10-28
NO831951L (no) 1983-12-02
AU569033B2 (en) 1988-01-21
DE3379502D1 (en) 1989-05-03
IL68833A0 (en) 1983-09-30
PT76783B (en) 1986-05-05
NO158805C (no) 1988-11-01
EP0096008A2 (en) 1983-12-07
GR78363B (ja) 1984-09-26
ES522815A0 (es) 1985-02-01
DK245383D0 (da) 1983-05-31
ZA833905B (en) 1984-01-25
CA1252108A (en) 1989-04-04
GB2122987B (en) 1985-09-25
US4510159A (en) 1985-04-09
DK245383A (da) 1983-12-02

Similar Documents

Publication Publication Date Title
CH637398A5 (de) Verfahren zur herstellung von maytansinoidverbindungen.
DD202531A5 (de) Verfahren zur herstellung von phamazeutisch wirksamen (3-aminopropoxy)-bibenzylderivaten
DE69704057T2 (de) Terphenylverbindungen und sie enthaltende arzneimittel
DE3413489C2 (ja)
DD210687A5 (de) Verfahren zur herstellung von (+)-cyanidan-3-ol-derivaten
EP0316279A2 (de) Veresterte azacyclische Hydroxyverbindungen
DE60012750T2 (de) Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
CH621780A5 (ja)
DD210042A5 (de) Verfahren zur herstellung von (plus + minus)-zyanidan-3-ol-abkoemmlingen
DE69019217T2 (de) Perylenquinon (UCN-1028D)-Derivate.
EP0400499B1 (de) Neue Acylaminosäurederivate enthaltende Arzneimittel und Diätetika
DE2128605A1 (de) Neue Cephalosporansäurederivaten und Verfahren zu ihrer Herstellung
DD154487A5 (de) Verfahren zur herstellung von 1-benzoxepin-5(2h)-on-derivaten
DE69719071T2 (de) Phenanthridiniumderivate
EP0213295B1 (de) Neue Thieno-1,2-thiazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE3407507A1 (de) Neue o-(2,6-dichloranilino)-phenylessigsaeureester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE1804983A1 (de) Verfahren zur Herstellung von Cephalosporansaeurederivaten
DE1670939A1 (de) Verfahren zur Herstellung von 2-Isothiuroniummethyl-3-carbon-saeureamido-chinoxalin-di-N-oxid-(1,4)-halogeniden
DE2753791A1 (de) Derivate von vincaalkaloiden, verfahren zu ihrer herstellung und arzneimittel
EP0196330B1 (de) Verwendung von pyrrothinderivaten
DE69326321T2 (de) Neues aminosäurederivat
CH616938A5 (en) Process for the preparation of 6beta-acylamino-1-oxadethiapenicillanic acids
DD290887A5 (de) Neue rifamycinderivate
CH637401A5 (de) Acylderivate der 2-(3-(2-chloraethyl)-3-nitrosoureido)-2-desoxy-d-glucopyranose.
DE102004005106A1 (de) Sorbifuranone, Sorbivineton, Sorbivinetol und Derivate dieser Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee
ENJ Ceased due to non-payment of renewal fee